Examkin

Soru

Zorluk: OrtaPharmacologic Interventions

A 23-year-old woman presents to the outpatient clinic reporting a 3-day history of lower abdominal pain and increased vaginal discharge. She has a new male sexual partner and notes inconsistent condom use. Her temperature is 38.1∘C38.1^\circ\text{C} (100.6∘F100.6^\circ\text{F}), blood pressure is 112/72 mm Hg112/72\text{ mm Hg}, and pulse is 88/min88\text{/min}. She denies nausea or vomiting and is tolerating an oral diet well. Pelvic examination reveals a friable cervix with yellow mucopurulent discharge, pronounced cervical motion tenderness, and bilateral adnexal tenderness. A point-of-care urine pregnancy test is negative. Which of the following pharmacologic interventions should be included in the initial empiric treatment regimen for this patient? (Select all that apply)

  1. Ceftriaxone intramuscularlyCevap
  2. Doxycycline orallyCevap
  3. Metronidazole orallyCevap
  4. D
    Azithromycin orally
  5. E
    Cefoxitin intravenously

Cevap

The correct empiric regimen includes intramuscular ceftriaxone, oral doxycycline, and oral metronidazole.
The patient presents with classic signs of pelvic inflammatory disease (PID). Because she lacks indications for hospitalization (such as pregnancy, severe illness, inability to tolerate oral medications, or a suspected tubo-ovarian abscess), outpatient management is appropriate. The standard empiric outpatient regimen for PID must provide broad coverage for Neisseria gonorrhoeae, Chlamydia trachomatis, and pelvic anaerobes. The guideline-directed regimen consists of a single dose of intramuscular ceftriaxone, combined with a 14-day course of oral doxycycline and a 14-day course of oral metronidazole.

Adım Adım Çözüm

1
Identify the clinical syndrome from the patient's presentation.
The patient has pelvic inflammatory disease (PID), indicated by lower abdominal pain, cervical motion tenderness, and adnexal tenderness in a young, sexually active female.
Establishing the diagnosis determines the necessary spectrum of antimicrobial coverage.
2
Determine the appropriate setting for treatment.
The patient should be treated in an outpatient setting.
She lacks indications for hospitalization, such as pregnancy, severe systemic illness, inability to tolerate oral medications, or suspected tubo-ovarian abscess.
3
Select the correct empiric antimicrobial regimen for outpatient management.
The regimen must cover Neisseria gonorrhoeae, Chlamydia trachomatis, and vaginal/pelvic anaerobes.
Current guidelines recommend a single dose of intramuscular ceftriaxone combined with a 14-day course of both oral doxycycline and oral metronidazole.

Anahtar Kavram

Outpatient empiric pharmacologic management of pelvic inflammatory disease
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru